AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered, structured, and analyzed by LLMs. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AI in Drug Discovery: 2025 in Review — Insilico Medicine Hits Phase IIa Milestone
Insilico Medicine achieved the first positive Phase IIa results for a fully AI-designed drug, while the Recursion-Exscientia merger created an end-to-end AI drug discovery platform. Over 200 AI-discovered drugs are now in development.
Google DeepMind CEO Says AI-Designed Drugs Are Entering Clinical Trials
Demis Hassabis announced that pharmaceutical drugs designed by AI at Isomorphic Labs are entering clinical trials, marking a new chapter in AlphaFold's journey from protein structure prediction to active drug design.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
Claude analyzes each source, extracts key information, and produces structured articles with categories, tags, and analytical context.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.